Atwood & Palmer’s Trinity Biotech TRIB Stock Holding History

Atwood & Palmer’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8	Hold	1	–	–	﹤0.01%	493
2026 Q1	$11	Hold	1	–	–	﹤0.01%	528
2025 Q4	$16	Hold	1	–	–	﹤0.01%	483
2025 Q3	$21	Hold	1	–	–	﹤0.01%	482
2025 Q2	$13	Hold	1	–	–	﹤0.01%	509
2025 Q1	$12	Hold	1	–	–	﹤0.01%	437
2024 Q4	$18	Hold	1	–	–	﹤0.01%	466
2024 Q3	$22	Hold	1	–	–	﹤0.01%	469
2024 Q2	$43	Hold	1	–	–	﹤0.01%	432
2024 Q1	$41	Hold	1	–	–	﹤0.01%	410
2023 Q4	$43	Hold	1	–	–	﹤0.01%	398
2023 Q3	$74	Hold	1	–	–	﹤0.01%	411
2023 Q2	$96	Hold	1	–	–	﹤0.01%	391
2023 Q1	$94	Hold	1	–	–	﹤0.01%	365
2022 Q4	$99	Hold	1	–	–	﹤0.01%	385
2022 Q3	$0	Hold	1	–	–	﹤0.01%	403
2022 Q2	$0	Hold	1	–	–	﹤0.01%	445
2022 Q1	$0	Hold	1	–	–	﹤0.01%	466
2021 Q4	$0	Hold	1	–	–	﹤0.01%	463
2021 Q3	$0	Hold	1	–	–	﹤0.01%	442
2021 Q2	$0	Hold	1	–	–	﹤0.01%	449
2021 Q1	$0	Hold	1	–	–	﹤0.01%	453
2020 Q4	$0	Hold	1	–	–	﹤0.01%	386
2020 Q3	$0	Hold	1	–	–	﹤0.01%	345
2020 Q2	$0	Hold	1	–	–	﹤0.01%	329
2020 Q1	$0	Hold	1	–	–	﹤0.01%	325
2019 Q4	$0	Hold	1	–	–	﹤0.01%	303
2019 Q3	$0	Hold	1	–	–	﹤0.01%	315
2019 Q2	$0	Hold	1	–	–	﹤0.01%	332
2019 Q1	$0	Hold	1	–	–	﹤0.01%	336
2018 Q4	$0	Hold	1	–	–	﹤0.01%	334
2018 Q3	$0	Hold	1	–	–	﹤0.01%	332
2018 Q2	$1K	Hold	1	–	–	﹤0.01%	307
2018 Q1	$1K	Hold	1	–	–	﹤0.01%	288
2017 Q4	$1K	Hold	1	–	–	﹤0.01%	285
2017 Q3	$1K	Hold	1	–	–	﹤0.01%	294
2017 Q2	$1K	Hold	1	–	–	﹤0.01%	314
2017 Q1	$1K	Hold	1	–	–	﹤0.01%	293
2016 Q4	$1K	Hold	1	–	–	﹤0.01%	328
2016 Q3	$1K	Hold	1	–	–	﹤0.01%	319
2016 Q2	$1K	Hold	1	–	–	﹤0.01%	302
2016 Q1	$1K	Hold	1	–	–	﹤0.01%	308
2015 Q4	$1K	Hold	1	–	–	﹤0.01%	393
2015 Q3	$1K	Hold	1	–	–	﹤0.01%	425
2015 Q2	$2K	Hold	1	–	–	﹤0.01%	356
2015 Q1	$2K	Hold	1	–	–	﹤0.01%	312
2014 Q4	$2K	Hold	1	–	–	﹤0.01%	366
2014 Q3	$2K	Hold	1	–	–	﹤0.01%	366
2014 Q2	$2K	Buy	+1	New	+$3.56K	﹤0.01%	317

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Atwood & Palmer's TRIB Position: Q2 2026 in Review

Atwood & Palmer held its Trinity Biotech (TRIB) position steady in Q2 2026 at 1 share worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Atwood & Palmer first reported a position in TRIB in Q2 2014 and has held it in 49 quarters since. The position peaked at $2K in Q2 2015. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

Atwood & Palmer held 1 share of Trinity Biotech worth $8 as of Q2 2026.
Atwood & Palmer left its Trinity Biotech share count unchanged in Q2 2026.
Trinity Biotech made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #493 holding.
Atwood & Palmer first reported a position in Trinity Biotech in Q2 2014 and has held it in 49 quarters since.
Atwood & Palmer's Trinity Biotech position peaked at $2K in Q2 2015.
19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.